Biogen Idec GmbH

Biotechnology

Products/services: Autoimmune Diseases; Research, Production and Distribution of Drugs

    • Short facts
      • Manufacturer
    • Year founded 1978
    • 200 Employees (site)
    • Turnover: 10m - <50m EUR
    Company
    Biogen Idec GmbH
    Street
    Carl-Zeiss-Ring 6
    PC/City
    85737 Ismaning
    County
    München / Upper Bavaria
    Phone
    +49 89 99617-0
    Fax
    +49 89 99617-199
    Email
    germany.information@biogenidec.com
    Homepage
    http://www.biogenidec.de
    Language skills
    German
    Location Map
    Key to Bavaria Map
  • Core competencies

    Biogen Idec, Inc., winner of the 1998 U.S. National Medal of Technology, is a biopharmaceutical company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. Headquartered in Cambridge, MA, the Company's revenues are generated from U.S. and European sales of AVONEX® (Interferon beta-1a) for treatment of relapsing forms of multiple sclerosis, and from the worldwide sales by licensees of a number of products, including alpha interferon and hepatitis B vaccines and diagnostic products. Biogen Idec's research and development activities are focused on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases and in developmental biology and gene therapy.

    Key sectors / sub-sectors
    • Biotechnology: Molecular diagnostics for humans
    • Biotechnology: Therapeutic drug development
    Certification

    not available

    Sales markets - target industries
    not available
    Sales markets - target countries
    not available
    Cooperation offers
    not available